PaxMedica Inc - PXMD STOCK NEWS

IMPACT

SENTIMENT

11/22/2023 04:10 PM

PXMD : Nasdaq

PaxMedica Announces Closing of $7.0 Million Public Offering

IMPACT

SENTIMENT

11/20/2023 09:15 AM

PXMD : Nasdaq

PaxMedica Announces Pricing of $7.0 Million Public Offering

IMPACT

SENTIMENT

11/17/2023 08:00 AM

PXMD : Nasdaq

PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data

IMPACT

SENTIMENT

11/15/2023 06:50 PM

PXMD : Nasdaq

PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Update

IMPACT

SENTIMENT

11/07/2023 08:00 AM

PXMD : Nasdaq

PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal

IMPACT

SENTIMENT

11/02/2023 08:30 AM

PXMD : Nasdaq

PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)

IMPACT

SENTIMENT

10/31/2023 08:00 AM

PXMD : Nasdaq

PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101

IMPACT

SENTIMENT

10/30/2023 11:30 AM

PXMD : Nasdaq

PaxMedica Announces 1-for-17 Reverse Stock Split

IMPACT

SENTIMENT

10/26/2023 01:51 PM

PXMD : Nasdaq

PaxMedica's Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication

IMPACT

SENTIMENT

10/26/2023 08:00 AM

PXMD : Nasdaq

PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data

PaxMedica Inc

Nasdaq:PXMD

PXMD Rankings

N/A Ranked by Market Cap

N/A Ranked by Dividends

PXMD Stock Data

Industry Biotechnology

Sector Healthcare

Website Link

Country United States

City Tarrytown